|Bioimpedance analysis versus lung ultrasonography for optimal risk prediction in hemodialysis patients|
D Siriopol, L Voroneanu, S Hogas, M Apetrii, A Gramaticu, R Dumea, ...
The international journal of cardiovascular imaging 32 (2), 263-270, 2016
|The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review|
B Afsar, D Siriopol, G Aslan, OC Eren, T Dagel, U Kilic, A Kanbay, ...
International urology and nephrology 50 (5), 885-904, 2018
|Optical characterization of hierarchical ZnO structures grown with a simplified vapour transport method|
VV Ursaki, EV Rusu, A Sarua, M Kuball, GI Stratan, A Burlacu, ...
Nanotechnology 18 (21), 215705, 2007
|Sudden cardiac death in dialysis patients: different causes and management strategies|
S Genovesi, G Boriani, A Covic, RWM Vernooij, C Combe, A Burlacu, ...
Nephrology Dialysis Transplantation 36 (3), 396-405, 2021
|Tuberculosis and COVID-19: lessons from the past viral outbreaks and possible future outcomes|
R Crisan-Dabija, C Grigorescu, CA Pavel, B Artene, IV Popa, A Cernomaz, ...
Canadian Respiratory Journal 2020, 2020
|Religiosity, spirituality and quality of life of dialysis patients: a systematic review|
A Burlacu, B Artene, I Nistor, S Buju, D Jugrin, I Mavrichi, A Covic
International urology and nephrology 51 (5), 839-850, 2019
|Atherosclerotic Renal Artery Stenosis Prevalence and Correlations in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Interventions: Data From …|
A Burlacu, D Siriopol, L Voroneanu, I Nistor, S Hogas, A Nicolae, ...
Journal of the American Heart Association 4 (10), e002379, 2015
|Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients|
S Badarau, D Siriopol, D Drugus, R Dumea, S Hogas, M Blaj, ...
International urology and nephrology 47 (10), 1703-1708, 2015
|The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients|
A Burlacu, S Genovesi, A Ortiz, M Kanbay, P Rossignol, M Banach, ...
Nephrology Dialysis Transplantation 32 (12), 1967-1976, 2017
|Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update|
A Burlacu, S Genovesi, A Ortiz, C Combe, C Basile, D Schneditz, ...
Nephrology Dialysis Transplantation 34 (6), 923-933, 2019
|“A chain only as strong as its weakest link”: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19|
R Crisan-Dabija, CA Pavel, IV Popa, A Tarus, A Burlacu
Journal of Proteome Research 19 (11), 4327-4338, 2020
|“Celebrating old age”: an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among …|
A Burlacu, I Mavrichi, R Crisan-Dabija, D Jugrin, S Buju, B Artene, A Covic
Archives of Medical Science: AMS 17 (2), 285, 2021
|A brand-new cardiorenal syndrome in the COVID-19 setting|
M Apetrii, S Enache, D Siriopol, A Burlacu, A Kanbay, M Kanbay, ...
Clinical Kidney Journal 13 (3), 291-296, 2020
|Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations|
A Covic, S Genovesi, P Rossignol, PA Kalra, A Ortiz, M Banach, A Burlacu
BMC medicine 16 (1), 1-11, 2018
|Bleeding in advanced CKD patients on antithrombotic medication–a critical appraisal|
A Burlacu, S Genovesi, D Goldsmith, P Rossignol, A Ortiz, PA Kalra, ...
Pharmacological research 129, 535-543, 2018
|Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy|
RM Busuioc, A Covic, M Kanbay, M Banach, A Burlacu, G Mircescu
Nephrology Dialysis Transplantation 35 (10), 1663-1674, 2020
|Curbing the AI-induced enthusiasm in diagnosing COVID-19 on chest X-rays: the present and the near-future|
A Burlacu, R Crisan-Dabija, IV Popa, B Artene, V Birzu, M Pricop, ...
|Unpuzzling COVID-19 prothrombotic state: are preexisting thrombophilic risk profiles responsible for heterogenous thrombotic events?|
A Burlacu, S Genovesi, IV Popa, R Crisan-Dabija
Clinical and Applied Thrombosis/Hemostasis 26, 1076029620952884, 2020
|A comprehensive review on apolipoproteins as nontraditional cardiovascular risk factors in end-stage renal disease: current evidence and perspectives|
C Vlad, A Burlacu, L Florea, B Artene, S Badarau, A Covic, C Ureche, ...
International urology and nephrology 51 (7), 1173-1189, 2019
|Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?|
PA Kalra, A Burlacu, CJ Ferro, A Covic
Current opinion in nephrology and hypertension 27 (6), 420-425, 2018